Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03121287 · ClinicalTrials.gov registry record
Early Imaging Biomarkers in NSCLC
A clinical trial of Thoracic Cancer, sponsored by University of Michigan Rogel Cancer Center.
- Completed
- Registry status
- 23
- Enrollment target
- 1
- Study location
NCT03121287 is a study of Thoracic Cancer that has completed, run by University of Michigan Rogel Cancer Center. The registered enrollment target is 23 participants, below the 347-participant average among 15 other Thoracic Cancer trials with a reported enrollment target (93% lower). The trial reports 1 study location across 1 state.
The verdict
NCT03121287, a study of Thoracic Cancer, has completed, sponsored by University of Michigan Rogel Cancer Center.
- COMPLETED
- Registry status
- 23 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to investigate if cardiac MRI, blood biomarkers, and lung CT scans can detect early changes to the associated with radiation therapy in patients receiving radiation treatment for thoracic cancer.
Conditions Studied
Interventions
- OTHER Specimen Collection
- OTHER Imaging
- OTHER Imaging Biomarkers
- OTHER Pulmonary
Study Locations (1)
Michigan
- University of Michigan - Ann Arbor
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 23 participants |
| Start Date | 2015-09-23 |
| Est. Completion | 2019-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03121287
The ClinicalTrials.gov registry entry for NCT03121287 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 23 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 347-participant average among 15 other Thoracic Cancer trials with a reported enrollment target (93% lower). The listed sponsor is University of Michigan Rogel Cancer Center, which has 292 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Thoracic Cancer appearing as the primary indexed condition, and to 4 interventions - of which Specimen Collection is the first listed.
NCT03121287 reports 1 study location spanning 1 distinct geographic area - top geographies include Michigan.
Frequently Asked Questions
What is clinical trial NCT03121287 about?
NCT03121287 is a clinical study titled "Early Imaging Biomarkers in NSCLC". The purpose of this study is to investigate if cardiac MRI, blood biomarkers, and lung CT scans can detect early changes to the associated with radiation therapy in patients receiving radiation treatment for thoracic cancer.
What is the current status of trial NCT03121287?
This trial is currently completed. The enrollment target is 23 participants. The study started on 2015-09-23. Estimated completion is 2019-01.
What conditions does trial NCT03121287 study?
This clinical trial studies the following conditions: Thoracic Cancer.
What interventions are being tested in trial NCT03121287?
The interventions under investigation include: Specimen Collection (OTHER), Imaging (OTHER), Imaging Biomarkers (OTHER), Pulmonary (OTHER).
Who is sponsoring clinical trial NCT03121287?
This trial is sponsored by University of Michigan Rogel Cancer Center, which has 292 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03121287 being conducted?
This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Thoracic Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Prospective Evaluation of Pencil Beam Scanning Proton Therapy for Previously Irradiated Tumors
RECRUITING · NA
-
Erector Spinae Block for Thoracic Surgery
RECRUITING · Phase 4
-
A Study Evaluating the Integrative Medicine at Home (IM@HOME) Program in People With Cancer
RECRUITING · NA
-
Fatigue and Molecular Mechanisms in Cancer Patients Receiving CCRT
RECRUITING
-
Study to Evaluate the Safety, Tolerability & Efficacy of TNG462 in Combination in PDAC & NSCLC Patients
RECRUITING · Phase 1
-
SURGE: Supporting UnderRepresented Minorities in Genomics-based Cancer Trial Enrollment (Intervention)
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.